Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3481
+0.0136 (4.07%)
At close: Jun 16, 2025, 4:00 PM
0.3482
+0.0001 (0.03%)
After-hours: Jun 16, 2025, 4:00 PM EDT
Turnstone Biologics Market Cap
Turnstone Biologics has a market cap or net worth of $8.06 million as of June 16, 2025. Its market cap has decreased by -86.76% in one year.
Market Cap
8.06M
Enterprise Value
-13.00M
1-Year Change
-86.76%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since the IPO on July 21, 2023, Turnstone Biologics's market cap has decreased from $255.86M to $8.06M, a decrease of -96.85%. That is a compound annual growth rate of -83.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 7.74M | -32.65% |
| Dec 31, 2024 | 11.49M | -80.45% |
| Dec 29, 2023 | 58.77M | -77.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |